Uss Investment Management LTD Organon & Co. Transaction History

Uss Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$23.31 - $28.61 $108,997 - $133,780	4,676 Added 5.75%	86,002 $2.4 Million
Q3 2022 Nov 08, 2022	BUY	$23.4 - $34.25 $109,231 - $159,879	4,668 Added 6.09%	81,326 $1.9 Million
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $1.25 Million - $1.53 Million	-39,420 Reduced 33.96%	76,658 $2.59 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $2.33 Million - $3.02 Million	76,658 Added 194.46%	116,078 $4.06 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $4.9 Million - $6.1 Million	-171,110 Reduced 81.28%	39,420 $1.29 Million
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $5.99 Million - $8 Million	210,530 New	210,530 $6.37 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Uss Investment Management LTD with notifications on news.